← back to search

Sameer Bakhshi

All India Institute of Medical Sciences Rishikesh · IN
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Sarcoma Diagnosis and Treatment, and Lymphoma Diagnosis and Treatment.
h-index
43
citations
8,851
works
911
NIH funding
primary concept
email

Recent publications

Assessing the Impact of Rituximab on Treatment Outcomes in Pediatric Advanced Mature B-Non Hodgkin Lymphoma.
2026cited by 0position: contributordoi
PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia.
2026cited by 0position: contributordoi
A Challenging Case of Pediatric Cardiac Leiomyosarcoma: Surgery, Recurrence, and Remission With Tyrosine Kinase Inhibitor.
2026cited by 0position: contributordoi
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study.
2026cited by 0position: contributordoi
Defective mitochondrial unfolded protein response in cancer acts as a lifeline for tumor growth and survival
Cell Stress and Chaperones 2026cited by 0position: contributordoi
Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients
JAMA Network Open 2025cited by 46position: middledoi
Prognostic significance of melanogenesis pathway and its association with the ultrastructural characterisation of melanosomes in uveal melanoma.
2025cited by 3position: contributordoi
Prevalence and Perception of Complementary and Alternative Medicine Use Among Childhood Cancer Patients: A Mixed-Methods Study.
2025cited by 1position: contributordoi
Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North India.
2025cited by 1position: contributordoi
Unravelling the Gut-Tumor Axis in Neuroblastoma: Promising Leads and Cautionary Gaps.
2025cited by 0position: contributordoi
Nuances in the Treatment of Ewing Sarcoma of the Head and Neck in a Low-Middle-Income Country Setting: A Multi-Disciplinary Approach.
2025cited by 0position: contributordoi
Gene expression signature of IKZF1 deleted B-cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4.
2025cited by 0position: contributordoi
The Utility and Impact of Telemedicine in Childhood Cancer Care: A Mixed Methods Study.
2025cited by 0position: contributordoi
Comment on: Cost-effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India.
2025cited by 0position: contributordoi
Primary Mediastinal Germ Cell Tumors: A Real-World Analysis of Clinical Characteristics, Treatment, and Survival Outcomes From Two Tertiary Cancer Centers in India.
2025cited by 0position: contributordoi
Impact of Gender of the Child on Health Care-Seeking Behavior of Caregivers of Childhood Patients With Cancer: A Mixed-Methods Study.
2025cited by 0position: contributordoi
Role of miRNA in diagnosis of Wilms tumor and neuroblastoma.
2025cited by 0position: contributordoi
Prostate-Related Germline Variant Frequencies Detected in a Cohort of Men With Metastatic Prostate Cancer in Northern India.
2025cited by 0position: contributordoi
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India.
2025cited by 0position: contributordoi
Mitophagy-Driven Prognosis in Pediatric Acute Myeloid Leukemia: A New Frontier
2025cited by 0position: contributordoi
The <i>HOTAIRM1-miR-222</i> Axis Regulates Venetoclax Resistance and Defines a High-Risk Subset in Pediatric t(8;21) Acute Myeloid Leukemia
2025cited by 0position: contributordoi
Primary Ewing sarcoma of the uterine cervix: a case report and comprehensive review
Korean Journal of Clinical Oncology 2025cited by 0position: contributordoi
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.
2024cited by 17position: contributordoi
Implications of LAG3 and CTLA4 immune checkpoints beyond PD-1/PD-L1 as a potential target in determining the prognosis of uveal melanoma patients.
2024cited by 8position: contributordoi
Cost-Effectiveness of Adjuvant Abemaciclib and Ribociclib in High-Risk Hormone Receptor-Positive Early Breast Cancer: An Indian Perspective.
2024cited by 7position: contributordoi
Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10-colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity.
2024cited by 4position: contributordoi
Sex Bias in Treatment Abandonment of Childhood Cancer in India.
2024cited by 3position: contributordoi
Philadelphia Chromosome Positive and Philadelphia-Like Acute Lymphoblastic Leukemia in Children and Adolescents: Current Management, Controversies and Emerging Concepts.
2024cited by 3position: contributordoi
Olanzapine cost-effectiveness in vomiting and nausea from highly emetogenic chemotherapy in children and adolescents.
2024cited by 3position: contributordoi
Translation and Psychometric Evaluation of the Hindi Language Version of the Pediatric Nausea Assessment Tool (PeNAT) in the Indian Population.
2024cited by 2position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 63 papers (2019–2026)Shuvadeep Ganguly · All India Institute of Medical Sciences Raipur14 papers (2020–2026)Deepam Pushpam · All India Institute of Medical Sciences11 papers (2020–2026)Atul Batra · All India Institute of Medical Sciences7 papers (2024–2025)Rachna Seth · All India Institute of Medical Sciences6 papers (2021–2026)Venkatraman Radhakrishnan · Manipal Academy of Higher Education5 papers (2021–2026)Manraj Singh Sra · Toyota Motor Corporation (Switzerland)5 papers (2024–2025)Raja Pramanik · All India Institute of Medical Sciences5 papers (2019–2025)Aditya Gupta · Thapar Institute of Engineering & Technology4 papers (2020–2025)Atul Sharma · All India Institute of Medical Sciences Raipur4 papers (2024–2025)Ritu Gupta · All India Institute of Medical Sciences4 papers (2023–2025)Jagdish Prasad Meena · Elsevier, Inc.4 papers (2020–2025)Sandeep Agarwala · Springer Nature4 papers (2020–2025)Sanjeev Kumar Gupta · Elsevier, Inc.4 papers (2023–2025)Smeeta Gajendra · All India Institute of Medical Sciences4 papers (2023–2025) · 4 papers (2021–2024) · 4 papers (2020–2025)Ranjit K. Sahoo · Springer Nature4 papers (2025–2025)Chitrakshi Nagpal · All India Institute of Medical Sciences4 papers (2024–2025) · 4 papers (2021–2026)